Gunther Birznieks Vanda Pharmaceuticals Inc. (VNDA) insider trading activity

VNDA Quotes by TradingView

Gunther Birznieks is SVP, Business Development of Vanda Pharmaceuticals Inc.. Currently has a direct ownership of 313,569 shares of VNDA, which is worth approximately $1.6 Million. The most recent transaction as insider was on Mar 05, 2024, when has been sold 8,684 shares (Common Stock) at a price of $4.13 per share, resulting in proceeds of $35,864. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 314K
5.26% 3M change
52.23% 12M change
Total Value Held $1.6 Million

Gunther Birznieks Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2024
SELL
Open market or private sale
$35,864 $4.13 p/Share
8,684 Reduced 2.69%
313,569 Common Stock
Mar 04 2024
SELL
Open market or private sale
$37,526 $4.3 p/Share
8,727 Reduced 2.64%
322,253 Common Stock
Feb 16 2024
BUY
Grant, award, or other acquisition
-
125,000 Added 27.41%
330,980 Common Stock
Mar 03 2023
SELL
Open market or private sale
$51,757 $6.26 p/Share
8,268 Reduced 3.86%
205,980 Common Stock
Mar 02 2023
SELL
Open market or private sale
$52,755 $6.2 p/Share
8,509 Reduced 3.82%
214,248 Common Stock
Feb 16 2023
BUY
Grant, award, or other acquisition
-
32,700 Added 12.8%
222,757 Common Stock
Aug 26 2022
BUY
Exercise of conversion of derivative security
$3,900 $3.12 p/Share
1,250 Added 0.65%
190,057 Common Stock
Mar 02 2022
SELL
Open market or private sale
$129,797 $11.27 p/Share
11,517 Reduced 5.75%
188,807 Common Stock
Mar 01 2022
SELL
Open market or private sale
$45,700 $11.19 p/Share
4,084 Reduced 2.0%
200,324 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
32,700 Added 13.79%
204,408 Common Stock
Mar 02 2021
SELL
Open market or private sale
$302,318 $18.19 p/Share
16,620 Reduced 8.83%
171,708 Common Stock
Mar 01 2021
SELL
Open market or private sale
$71,748 $18.66 p/Share
3,845 Reduced 2.0%
188,328 Common Stock
Feb 24 2021
BUY
Grant, award, or other acquisition
-
32,700 Added 14.54%
192,173 Common Stock
GB

Gunther Birznieks

SVP, Business Development
Washington, DC

Track Institutional and Insider Activities on VNDA

Follow Vanda Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNDA shares.

Notify only if

Insider Trading

Get notified when an Vanda Pharmaceuticals Inc. insider buys or sells VNDA shares.

Notify only if

News

Receive news related to Vanda Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VNDA